180 related articles for article (PubMed ID: 2273999)
1. Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.
van der Rijt CC; de Knegt RJ; Schalm SW; Terpstra OT; Mechelse K
Metab Brain Dis; 1990 Sep; 5(3):131-41. PubMed ID: 2273999
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of acute hepatic encephalopathy with flumazenil].
Viel E; de La Coussaye JE; Bassoul B; Saissi G; Eledjam JJ
Ann Fr Anesth Reanim; 1990; 9(4):386-9. PubMed ID: 2119157
[TBL] [Abstract][Full Text] [Related]
3. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
[TBL] [Abstract][Full Text] [Related]
4. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
Als-Nielsen B; Kjaergard LL; Gluud C
Cochrane Database Syst Rev; 2001; (4):CD002798. PubMed ID: 11687160
[TBL] [Abstract][Full Text] [Related]
6. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
7. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
[TBL] [Abstract][Full Text] [Related]
8. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
Devictor D; Tahiri C; Lanchier C; Navelet Y; Durand P; Rousset A
Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615
[TBL] [Abstract][Full Text] [Related]
9. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
Ferenci P; Grimm G
Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine receptor antagonists for hepatic encephalopathy.
Als-Nielsen B; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2004; (2):CD002798. PubMed ID: 15106178
[TBL] [Abstract][Full Text] [Related]
11. Improvement of hepatic encephalopathy treated with flumazenil.
Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
[TBL] [Abstract][Full Text] [Related]
12. Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial.
Groeneweg M; Gyr K; Amrein R; Scollo-Lavizzari G; Williams R; Yoo JY; Schalm SW
Electroencephalogr Clin Neurophysiol; 1996 Jan; 98(1):29-34. PubMed ID: 8689991
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
[TBL] [Abstract][Full Text] [Related]
14. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy].
Pidoux B; Zylberberg P; Valla D; Opolon P
Neurophysiol Clin; 1989 Dec; 19(6):469-76. PubMed ID: 2559309
[TBL] [Abstract][Full Text] [Related]
15. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.
Goulenok C; Bernard B; Cadranel JF; Thabut D; Di Martino V; Opolon P; Poynard T
Aliment Pharmacol Ther; 2002 Mar; 16(3):361-72. PubMed ID: 11876688
[TBL] [Abstract][Full Text] [Related]
16. [The use of flumazenil in the treatment of hepatic encephalopathy secondary to acute liver failure. A report of 2 cases].
Díaz de León-Ponce M; Eid-Lidt G; Castañón-González JA; Deseaño-Estudillo JL; Reyes B
Gac Med Mex; 1993; 129(5):347-50. PubMed ID: 7926421
[No Abstract] [Full Text] [Related]
17. The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study.
Dursun M; Caliskan M; Canoruc F; Aluclu U; Canoruc N; Tuzcu A; Yilmaz S; Isikdogan A; Ertem M
Swiss Med Wkly; 2003 Feb; 133(7-8):118-23. PubMed ID: 12644958
[TBL] [Abstract][Full Text] [Related]
18. Flumazenil in the treatment of portal systemic encephalopathy--an overview.
Gyr K; Meier R
Intensive Care Med; 1991; 17 Suppl 1():S39-42. PubMed ID: 1774410
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hepatic encephalopathy with flumazenil].
Elkjaer JM; Jensen TU; Emborg J
Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
[TBL] [Abstract][Full Text] [Related]
20. [The quantitative electroencephalogram in a case of acute hepatic encephalopathy treated with flumazenil].
Frenkel AL; Hermant JL; Blaise M; Volter F; Pourriat JL
Cah Anesthesiol; 1991; 39(1):61-2. PubMed ID: 2054699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
